Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
08. Juni 2026 09:00 ET | Quelle: Centre d’excellence sur la douleur chronique pour les vétérans canadiens
HAMILTON, Ontario, 08 juin 2026 (GLOBE NEWSWIRE) -- Un rapport national récemment publié appelle à une action urgente et coordonnée pour lutter contre la douleur chronique chez les femmes et les...
-
HONG KONG, June 08, 2026 (GLOBE NEWSWIRE) -- AgentOn, an AI-native task network designed for the emerging AI Agent economy, has officially launched its platform alongside a $100,000 bounty campaign...
-
Houston, TX, June 08, 2026 (GLOBE NEWSWIRE) -- Patriot Mobile, America’s only Christian conservative wireless provider, is proud to announce they are the Title Sponsor of the American Patriots Gala...
-
Atlanta, Georgia, June 08, 2026 (GLOBE NEWSWIRE) -- Outdoor Holding Company (NASDAQ: POWW/POWWP) (“Outdoors Online,” “we,” “us.” “our” or the “Company”), the owner of GunBroker.com, the largest...
-
VANCOUVER, British Columbia, June 08, 2026 (GLOBE NEWSWIRE) -- ANORTECH INC. (“AnorTech” or the “Company”) (TSX Venture Exchange “ANOR”; OTC “ANORF”) is pleased to announce a new collaboration with...
-
RISHON LE ZION, Israel, June 08, 2026 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. ("BOS" or the "Company") (NASDAQ: BOSC), an integrator of supply chain technologies for the aerospace,...
-
BASKING RIDGE, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- All customers with telephone numbers with the 347/718/917/929 area codes should be aware of the introduction of the new 465 area code....
-
At 20x lower cost than competitors, NV2 democratizes access to live, full HD AI presence to improve customer experiences and employee engagement.
-
Fat Brain Toys brings the brainteaser collection to U.S. retail with hands-on, screen-free puzzles that blend entertainment with brain-challenging play.
-
ADARx to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress